| 标题 |
Updated efficacy and safety results of the Bruton tyrosine kinase (BTK) degrader BGB-16673 in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) from the ongoing phase 1 CaDAnCe-101 study |
| 网址 | |
| DOI |
10.1182/blood-2025-85
doi
|
| 其它 |
期刊:Blood 作者:Inhye E. Ahn; Ricardo D. Parrondo; Meghan C. Thompson; A. Frustaci; John N. Allan; et al 出版日期:2025-11-03 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)